27 research outputs found

    Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study

    Get PDF
    AbstractWe assessed the persistence of hepatitis B surface antigen antibody (anti-HBs) and immune memory in a cohort of 571 teenagers vaccinated against hepatitis B as infants, 17 years earlier. Vaccinees were followed-up in 2003 and in 2010 (i.e. 10 years and 17 years after primary vaccination, respectively). When tested in 2003, 199 vaccinees (group A) had anti-HBs <10 mIU/mL and were boosted, 372 (group B) were not boosted because they had anti-HBs ≥10 mIU/mL (n = 344) or refused booster (n = 28) despite anti-HBs <10 mIU/mL. In 2010, 72.9% (416/571) of participants had anti-HBs ≥10 mIU/mL (67.3% in group A vs. 75.8% in group B; p 0.03). The geometric mean concentrations (GMCs) were similar in both groups. Between 2003 and 2010, anti-HBs concentrations in previously boosted individuals markedly declined with GMC dropping from 486 to 27.7 mIU/mL (p <0.001). Fifteen vaccinees showed a marked increase of antibody, possibly due to natural booster. In 2010, 96 individuals (37 of group A and 59 of group B) with anti-HBs <10 mIU/mL were boosted; all vaccinees of the former group and all but two of the latter had an anamnestic response. Post-booster GMC was higher in group B (895.6 vs. 492.2 mIU/mL; p 0.039). This finding shows that the immune memory for HBsAg persists beyond the time at which anti-HBs disappears, conferring long-term protection

    Prevalenza dei sintomi soggettivi negli addetti alla Risonanza Magnetica per Immagini (RMI) presso l’Azienda Sanitaria Provinciale di Potenza

    No full text
    Abbiamo confrontato la prevalenza di alcuni sintomi soggettivi tra operatori della Diagnostica per Immagini addetti alla RMI e non addetti. Il 63,6% degli addetti alla RMI ha lamentato almeno un sintomo contro il 50% dei controlli ed inoltre anche il numero medio e la prevalenza di alcuni sintomi sono risultati maggiori nel primo gruppo seppure non statisticamente significativi. Questo aumento di sintomi negli addetti alla RMI andrà confermato su casistiche più ampie
    corecore